New study finds HIV Achilles Heel

June 21, 2011 by Deborah Braconnier in HIV & AIDS report
hiv

Enlarge

Diagram of the HIV virus. Image: US National Institute of Health/Wikipedia.

(Medical Xpress) -- A new study published in the Proceedings of the National Academy of Sciences shows how scientists have used a mathematical tool to possibly identify an Achilles heel in HIV which may lead to new vaccines and treatments.

One of the main things that make so difficult to combat is its extreme ability to mutate. However, this research has identified what are being called HIV sectors and are groups of that are rarely seen making mutations. The researchers believe that the virus needs to maintain these sectors in order to survive and it is these sectors that should be the main target of treatments.

Through a joint enterprise combining the Massachusetts Institute of Technology, Harvard, University and Massachusetts General Hospital, the group called the Ragon Institute is behind the study. The Ragon Institute was established in 2009 to bring scientists together for the study in HIV/AIDS and other similar diseases.

The lead researchers were not biologists but rather specialized in chemistry. Professor of chemistry and chemical engineering at MIT Arup Chakraborty partnered with assistant professor of chemistry from the Universite Pierre et Marie Curie Vincent Dahirel. The two chemists joined forces with a long-time HIV researcher and director of the Ragon Institute Bruce Walker.

Using a 1950s statistical method known as , Chakraborty and Dahirel looked at the HIV proteins and sequences taken from a huge database of HIV patients trying to determine which segment was least able to tolerate mutations. What they found was sector three on the known as Gag.

It was determined that part of this sector was responsible for the outer edges of the that makes up the internal shell of the virus. If this structure suffered too many mutations, it would collapse.

New study finds HIV Achilles Heel

Ragon Institute researchers identified potential HIV vaccine targets in a subunit of the Gag protein. Six of those subunits come together to form the hexagonal proteins that make up the viral capsid. Image: Vincent Dahirel

Dr. Walker has spent years studying the rare HIV patients known as “elite controllers.” These patients are able to control their HIV virus with their own immune system and no medication. What they found was the main target of these patient’s immune system was this same sector three.

The main hypothesis determined from this study was that new vaccines and treatments should not focus on a random attack but a focused attack on sector three. Professor of Medicine at Harvard and fellow Ragon colleague Dan Barouch plans to test this hypothesis in monkeys.

More information: Coordinate linkage of HIV evolution reveals regions of immunological vulnerability, PNAS, Published online before print June 20, 2011, doi: 10.1073/pnas.1105315108

Abstract
Cellular immune control of HIV is mediated, in part, by induction of single amino acid mutations that reduce viral fitness, but compensatory mutations limit this effect. Here, we sought to determine if higher order constraints on viral evolution exist, because some coordinately linked combinations of mutations may hurt viability. Immune targeting of multiple sites in such a multidimensionally conserved region might render the virus particularly vulnerable, because viable escape pathways would be greatly restricted. We analyzed available HIV sequences using a method from physics to reveal distinct groups of amino acids whose mutations are collectively coordinated (“HIV sectors”). From the standpoint of mutations at individual sites, one such group in Gag is as conserved as other collectively coevolving groups of sites in Gag. However, it exhibits higher order conservation indicating constraints on the viability of viral strains with multiple mutations. Mapping amino acids from this group onto protein structures shows that combined mutations likely destabilize multiprotein structural interactions critical for viral function. Persons who durably control HIV without medications preferentially target the sector in Gag predicted to be most vulnerable. By sequencing circulating viruses from these individuals, we find that individual mutations occur with similar frequency in this sector as in other targeted Gag sectors. However, multiple mutations within this sector are very rare, indicating previously unrecognized multidimensional constraints on HIV evolution. Targeting such regions with higher order evolutionary constraints provides a novel approach to immunogen design for a vaccine against HIV and other rapidly mutating viruses.

© 2010 PhysOrg.com

4.8 /5 (13 votes)  

Filter


Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

Tenche
Jun 21, 2011

Rank: not rated yet
Woho! Stoked!
skicreature
Jun 21, 2011

Rank: 5 / 5 (2)
heck yeah... more engineers need to be getting involved with biology.... The engineering mindset of using advanced quantitative methods to solve problems can be applied everywhere... If we hadn't been using traditional biological methods of study maybe we would have made this discovery much earlier.
blazingspark
Jun 22, 2011

Rank: 5 / 5 (1)
Yes, the engineering approach to medicine seems to generate practical advances more quickly.
If you want a once off solution for a problem for a million dollars: ask a scientist.
If you want a solution for a million people at $1 each: ask an engineer.

I suppose we need both approaches at the same time. One to come up with the ideas, do the experiments, gather data. The other approach to effectively use the knowledge gained and put it to use in society today.
dsinla
Jun 25, 2011

Rank: not rated yet
Dr. Nancy Padian 10-year study on HIV transmission bit dot ly/lbJha6 (video) bit dot ly/kA0FjO (Paper)

Luc Montagnier says HIV Can Be Cleared Naturally bit dot ly/hSLsaF
Rank 4.8 /5 (13 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

Mortality rates decrease, chronic disease rates increase among HIV+ ICU patients

The expanded use of antiretrovirals, potent drugs used to treat retroviral infections such as human immunodeficiency virus (HIV), has been linked to significant decreases in hospital mortality rates among severely ill HIV-positive(HIV+) ...

HIV & AIDS created May 23, 2012 | popularity not rated yet | comments 0

Newly discovered breast milk antibodies help neutralize HIV

Antibodies that help to stop the HIV virus have been found in breast milk. Researchers at Duke University Medical Center isolated the antibodies from immune cells called B cells in the breast milk of infected mothers in Malawi, ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (3) | comments 1 | with audio podcast

Reactions to HIV drug have autoimmune cause, reports AIDS journal

Potentially severe hypersensitivity reactions to the anti-HIV drug abacavir occur through an autoimmune mechanism, resulting from the creation of drug-induced immunogens that are attacked by the body's immune system, according ...

HIV & AIDS created May 22, 2012 | popularity 5 / 5 (1) | comments 0

Is the U.S. ready for home HIV tests?

At the pharmacy, you can buy anything from tea kettles to Tylenol. But what if you could buy a rapid HIV test over the counter and test yourself in the privacy of your own home?

HIV & AIDS created May 21, 2012 | popularity not rated yet | comments 0 | with audio podcast

Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use

A change in the formulation of tenofovir gel, an anti-HIV gel developed for vaginal use, may make it safer to use in the rectum, suggests a study published online this week in the Journal of Antimicrobial Chemotherapy. In lab ...

HIV & AIDS created May 17, 2012 | popularity 5 / 5 (1) | comments 0


'Personality genes' may help account for longevity

"It's in their genes" is a common refrain from scientists when asked about factors that allow centenarians to reach age 100 and beyond. Up until now, research has focused on genetic variations that offer a physiological advantage ...

Amino acid consumption associated with how fast cancer cells divide

For almost a century, researchers have known that cancer cells have peculiar appetites, devouring glucose in ways that normal cells do not. But glucose uptake may tell only part of cancer's metabolic story. Researchers from ...

Gene discovery points towards non-hormonal male contraceptive

A new type of male contraceptive could be created thanks to the discovery of a key gene essential for sperm development.

Brentuximab vedotin effective in large-cell lymphoma

(HealthDay) -- More than half of patients with relapsed or refractory systemic anaplastic large-cell lymphoma (ALCL) treated with the CD30-directed antibody-drug conjugate brentuximab vedotin achieve a complete ...

Study provides compelling evidence for an effective new treatment for tinnitus

According to new research, a multidisciplinary approach to treating tinnitus that combines cognitive behaviour therapy with sound-based tinnitus retraining therapy is significantly more effective than currently available ...

Cyber exercise partners help you go the distance: Motivation gains can double

A new study testing the benefits of a virtual exercise partner shows the presence of a moderately more capable cycling partner can significantly boost the motivation – by as much as 100 percent – ...